Graf James A 4
4 · NKGen Biotech, Inc. · Filed Nov 22, 2023
Insider Transaction Report
Form 4
Graf James A
Chief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-11-21$2.92/sh+13$38→ 23 total - Purchase
Common Stock
2023-11-20$2.94/sh+10$29→ 10 total
Holdings
- 2,436,744(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.895 to $2.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]James A. Graf is the managing member of Graf Acquisition Partners IV LLC. Mr. Graf has voting and investment discretion with respect to the securities held of record by Graf Acquisition Partners IV LLC.